MILLENNIUM MANAGEMENT LLC - SUCAMPO PHARMACEUTICALS INC ownership

SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 82 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of SUCAMPO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$6,359,000
-30.8%
354,276
-54.5%
0.01%
-35.7%
Q3 2017$9,193,000
-13.4%
779,071
-23.0%
0.01%
-26.3%
Q2 2017$10,621,000
-33.1%
1,011,477
-29.9%
0.02%
-34.5%
Q1 2017$15,878,000
+26.9%
1,443,435
+56.3%
0.03%
+11.5%
Q4 2016$12,517,000
+54.6%
923,794
+40.5%
0.03%
+85.7%
Q3 2016$8,096,000
+73.0%
657,680
+54.2%
0.01%
+27.3%
Q2 2016$4,679,000
+144.2%
426,527
+143.3%
0.01%
+120.0%
Q1 2016$1,916,000
+49.8%
175,317
+136.9%
0.01%
+66.7%
Q4 2015$1,279,000
-69.5%
73,998
-65.0%
0.00%
-62.5%
Q3 2015$4,199,000
-48.1%
211,341
-57.0%
0.01%
-46.7%
Q2 2015$8,083,000
-35.5%
491,983
-38.9%
0.02%
-34.8%
Q1 2015$12,526,000
-6.8%
804,994
-14.5%
0.02%
-17.9%
Q4 2014$13,439,000
+476.5%
941,101
+162.4%
0.03%
+366.7%
Q3 2014$2,331,000
+12.7%
358,679
+19.6%
0.01%0.0%
Q2 2014$2,069,000
-33.8%
299,819
-31.4%
0.01%
-33.3%
Q1 2014$3,127,000
+206.3%
437,368
+302.5%
0.01%
+200.0%
Q4 2013$1,021,000
+217.1%
108,669
+110.4%
0.00%
+200.0%
Q3 2013$322,000
-17.4%
51,645
-12.8%
0.00%0.0%
Q2 2013$390,00059,2260.00%
Other shareholders
SUCAMPO PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 555,652$9,607,0003.06%
OBERWEIS ASSET MANAGEMENT INC/ 96,630$1,671,0000.47%
JUNCTURE WEALTH STRATEGIES, LLC 35,281$610,0000.46%
AWM Investment Company, Inc. 100,000$1,729,0000.34%
GLOBEFLEX CAPITAL L P 65,588$1,134,0000.30%
NEW AMSTERDAM PARTNERS LLC/NY 166,479$2,878,0000.30%
Convergence Investment Partners, LLC 100,850$1,744,0000.20%
GSA CAPITAL PARTNERS LLP 219,881$3,802,0000.19%
OXFORD ASSET MANAGEMENT LLP 433,219$7,672,0000.18%
Zebra Capital Management LLC 17,720$306,0000.17%
View complete list of SUCAMPO PHARMACEUTICALS INC shareholders